Federated added 2.3 M shares in Q1. It is nice to see this long time investor adding back the shares they sold earlier last year. They moved ahead of FMR as second largest shareholder. Institutional ownership actually is creeping back up.That is the most bullish news I've seen in a while.
When looking at the chart...VICL sits on support at 3.60 and the 200 day EMA, Williams % is very oversold and Parabolic SAR is ready to reverse directions.
When (not if) VICL becomes a $1billion market cap company, institutions will own at least 3/4 of the shares, so seeing uptick, as small as it may be, is a positive. Let's all remember that VICL expected a longer runway to Allovectin data lock over a year ago. Why? VICL increased the float in January, 2012 allowing more shares for individuals like Mr. Singer and institutions to buy in below $4. VICL is trading today at about the level it did in Q1 2012 when the float shares were bought/absorbed. No blockbuster news in 14 months on their two drug franchises -- cancer and CMV. But Vaxfectin has attracted big pharma interest with no financial terms disclosed, IMO since it's about "proof of efficacy" in R&D at this point for big pharma who may want a piece of VICL IP.
Paint is still drying......with the official end of trial data for Allovectin shown as August, 2013 on the FDA web site.